JScopeJapan Capex

Shionogi Pharma to install production equipment at Kanegasaki Plant

Pharma & MedicalIwate

Shionogi Pharma plans to invest ¥2.07 billion in production equipment at its Kanegasaki Plant in Iwate Prefecture. Construction is scheduled from January through December 2026 and will be funded internally; no post-investment capacity increase is disclosed.

Company
Shionogi Pharma Co., Ltd.
Investment
¥2.1B total
Location
Iwate
Announced
Jun 19, 2026
Ticker
4507
Phase
planned
Construction start
Jan 1, 2026
Completion
Dec 1, 2026
Want the full picture?See what you get

Olympus completes new B Building at Nagano site for medical-device component production

NewPharma & MedicalNaganoCompleted¥18B

Olympus has completed the new B Building at its Nagano site in Tatsuno, Nagano, consolidating development and manufacturing functions and establishing a production base for key medical-device components. Construction began in February 2025, with full operation targeted for FY2026; the building has 17,665 sqm of total floor area and a total construction cost of approximately ¥18 billion.

JGC completes Chugai Pharma's UT3 biopharmaceutical API facility in Utsunomiya

Pharma & MedicalTochigiCompleted

JGC Holdings completed the UT3 biopharmaceutical active pharmaceutical ingredient facility for Chugai Pharmaceutical Industry at its Utsunomiya plant in May 2026. The four-story facility supports clinical-trial manufacturing through initial commercial production and includes continuous-production capabilities, solar panels and other environmental features; it was handed over on May 14, 2026.

Lion to build new pharmaceutical plant in Hung Yen, Vietnam

Pharma & MedicalHung YenPlanned¥1.5B

Lion has approved construction of a new pharmaceutical plant through its wholly owned Vietnamese subsidiary Merap Lion. The facility will produce prescription and over-the-counter solid-dose medicines, including tablets and granules, with operations planned to begin in the second half of 2030.

Tsumura to build new quality-control facility to support stable supply

Pharma & MedicalIbarakiPlanned¥7B

Tsumura will build a new QC building and hazardous-materials warehouse at its Ibaraki Plant in Ami, Ibaraki, to strengthen quality-testing capacity and business continuity for its kampo pharmaceutical products. Construction costs approximately ¥7 billion, designed and built by Kajima Corporation, with completion planned for mid-April 2028.